MotherToBaby Launches First Lupus in Pregnancy Research Study
World-Renowned UC San Diego Epidemiologist Leads Groundbreaking Study(PRWeb February 01, 2023)Read the full story at https://www.prweb.com/releases/mothertobaby_launches_first_lupus_in_pregnancy_research_study/prweb19147999.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - February 1, 2023 Category: Pharmaceuticals Source Type: news
What is lupus? 1 in 200 people suffer from inflammation disorder that causes body to attack itself
She spoke out again about her lupus diagnosis after her social media followers pointed out how her hands were 'shaking' in a recent clip. (Source: the Mail online | Health)
Source: the Mail online | Health - January 31, 2023 Category: Consumer Health News Source Type: news
Muni Long On Her Grammy Nominations, Finding Her Voice Again & More
R&B star Muni Long talks about her three Grammy nominations, battling lupus and finding her singing voice again, and more!#rb #munilong #grammy (Source: Reuters: Health)
Source: Reuters: Health - January 31, 2023 Category: Consumer Health News Source Type: news
Study: Diminished COVID Vaccine Response in Lupus
(MedPage Today) -- Patients with systemic lupus erythematosus (SLE) showed reduced antibody responses following COVID-19 vaccination, with drugs for the condition such as belimumab (Benlysta) and mycophenolate mofetil (MMF) likely to blame, researchers... (Source: MedPage Today Rheumatology)
Source: MedPage Today Rheumatology - January 30, 2023 Category: Rheumatology Source Type: news
Black members pass motions on disability and cost of living crisis
There are an estimated 185,000 Black members in UNISON, the majority of whom work in health and local government services, and the union has declared 2023 as the Year of Black Workers.
During the morning session, chaired by Kebba Manneh – the chair of the national Black members committee – conference passed motions on young Black members and mental health at work, and on Black members feeling undervalued and like they don’t belong.
A key motion was unanimously passed on Black workers and non-apparent impairments.
Introduced by Tansaim Hussain-Gul of the union’s national disabled members committee, the motion calle...
Source: UNISON Health care news - January 22, 2023 Category: UK Health Authors: Janey Starling Tags: Article News 2023 National Black Members Conference cost of living disability Source Type: news
Belimumab for Pregnant Women With Lupus: B-Cell Concerns Remain Belimumab for Pregnant Women With Lupus: B-Cell Concerns Remain
The largest combined analysis of birth outcome data found no apparent increase in birth defects or pregnancy loss with belimumab.MDedge News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - January 17, 2023 Category: Dermatology Tags: Rheumatology News Source Type: news
Study identifies potential new approach for treating lupus
Targeting iron metabolism in immune system cells may offer a new approach for treating systemic lupus erythematosus (SLE) - the most common form of the chronic autoimmune disease lupus.
A multidisciplinary team of investigators at Vanderbilt University Medical Center has discovered that blocking an iron uptake receptor reduces disease pathology and promotes the activity of anti-inflammatory regulatory T cells in a mouse model of SLE. (Source: World Pharma News)
Source: World Pharma News - January 13, 2023 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news
CV Risk Score Multipliers Suggested for Rheumatic Diseases CV Risk Score Multipliers Suggested for Rheumatic Diseases
Guidelines could tailor cardiovascular risk scores by using a multiplier of 2.5 for systemic sclerosis, 2.0 for lupus, and 1.5 for any other rheumatic disease.MDedge News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - December 30, 2022 Category: Cardiology Tags: Rheumatology News Source Type: news
Upstate MD/PhD student awarded 2-year NIH grant for lupus research
Akshay Patel will use the funding to continue his work aimed at discerning the role played by a specific enzyme that is associated with the onset and worsening of lupus. (Source: SUNY Upstate Medical)
Source: SUNY Upstate Medical - December 29, 2022 Category: Universities & Medical Training Tags: News Source Type: news
IBD Patients on the Most Effective Ways Doctors Can Treat Their Condition
People who have inflammatory bowel disease (IBD)—which is the umbrella term for Crohn’s disease and ulcerative colitis—often experience a range of symptoms, from intense abdominal cramping and pain to persistent diarrhea and overwhelming fatigue. Living with IBD can significantly disrupt everyday life and make it challenging to maintain physical and mental wellbeing.
There’s no cure for IBD—it lasts a lifetime. Like other chronic conditions, IBD can go into remission with effective treatment, but people might still experience occasional flares that make life more difficult.
Approximately 1.6 m...
Source: TIME: Health - December 28, 2022 Category: Consumer Health News Authors: Elizabeth Millard Tags: Uncategorized Gut health healthscienceclimate Source Type: news
Lupus Linked With Greater Risk of Cardiovascular Complications of Childbirth
(MedPage Today) -- Pregnant women with systemic lupus erythematosus (SLE) were more prone to cardiovascular complications during delivery, and their risk seems to have increased over the past 15 years, according to national administrative data... (Source: MedPage Today Rheumatology)
Source: MedPage Today Rheumatology - November 29, 2022 Category: Rheumatology Source Type: news
ACR: Long-Term Safety Demonstrated for Anifrolumab in Lupus
MONDAY, Nov. 21, 2022 -- For patients with systemic lupus erythematosus (SLE), anifrolumab is safe in the long term, according to a study published online Nov. 11 in Arthritis& Rheumatology to coincide with the annual meeting of the American... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 21, 2022 Category: Pharmaceuticals Source Type: news
ACR: Low-Dose Hydroxychloroquine Tied to More Hospitalizations for Lupus Flares
FRIDAY, Nov. 18, 2022 -- Patients with systemic lupus erythematosus (SLE) who are treated with lower doses of hydroxychloroquine (HCQ) have an increased risk for hospitalizations for SLE flares, according to a study presented at the annual meeting... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 18, 2022 Category: Pharmaceuticals Source Type: news
Lower HCQ Dose for Lupus Tied to Hospitalizations for Flares Lower HCQ Dose for Lupus Tied to Hospitalizations for Flares
Longer-term HCQ-induced retinopathy risk must be balanced with shorter-term risk for hospitalization for an SLE flare from a lower dose, researchers say.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - November 14, 2022 Category: Dermatology Tags: Rheumatology News Source Type: news
HCQ in Lupus: No Heart Worries With Higher Doses
(MedPage Today) -- Patients with systemic lupus erythematosus (SLE) who received higher than normal doses of hydroxychloroquine (HCQ) to control their disease did not experience increased rates of serious cardiovascular events, researchers found... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - November 9, 2022 Category: Cardiology Source Type: news
